ZOETIS INC (ZTS) Fundamental Analysis & Valuation

NYSE:ZTS • US98978V1035

121.43 USD
-0.8 (-0.65%)
At close: Mar 6, 2026
121.43 USD
0 (0%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

ZTS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. ZTS scores excellent on profitability, but there are some minor concerns on its financial health. ZTS has a correct valuation and a medium growth rate. ZTS also has an excellent dividend rating. These ratings would make ZTS suitable for dividend investing!


Dividend Valuation Growth Profitability Health

9

1. ZTS Profitability Analysis

1.1 Basic Checks

  • ZTS had positive earnings in the past year.
  • ZTS had a positive operating cash flow in the past year.
  • In the past 5 years ZTS has always been profitable.
  • In the past 5 years ZTS always reported a positive cash flow from operatings.
ZTS Yearly Net Income VS EBIT VS OCF VS FCFZTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • The Return On Assets of ZTS (17.28%) is better than 96.37% of its industry peers.
  • The Return On Equity of ZTS (80.25%) is better than 99.48% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 21.95%, ZTS belongs to the top of the industry, outperforming 97.41% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZTS is significantly above the industry average of 13.00%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ZTS Yearly ROA, ROE, ROICZTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • ZTS has a Profit Margin of 28.23%. This is amongst the best in the industry. ZTS outperforms 93.26% of its industry peers.
  • In the last couple of years the Profit Margin of ZTS has grown nicely.
  • ZTS has a better Operating Margin (38.54%) than 96.89% of its industry peers.
  • ZTS's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ZTS (71.89%) is better than 78.76% of its industry peers.
  • ZTS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
ZTS Yearly Profit, Operating, Gross MarginsZTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ZTS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ZTS is creating value.
  • The number of shares outstanding for ZTS has been reduced compared to 1 year ago.
  • The number of shares outstanding for ZTS has been reduced compared to 5 years ago.
  • ZTS has a worse debt/assets ratio than last year.
ZTS Yearly Shares OutstandingZTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ZTS Yearly Total Debt VS Total AssetsZTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ZTS has an Altman-Z score of 5.65. This indicates that ZTS is financially healthy and has little risk of bankruptcy at the moment.
  • ZTS's Altman-Z score of 5.65 is fine compared to the rest of the industry. ZTS outperforms 77.20% of its industry peers.
  • The Debt to FCF ratio of ZTS is 3.96, which is a good value as it means it would take ZTS, 3.96 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ZTS (3.96) is better than 87.05% of its industry peers.
  • ZTS has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • ZTS's Debt to Equity ratio of 2.71 is on the low side compared to the rest of the industry. ZTS is outperformed by 79.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.65
ROIC/WACC2.44
WACC9%
ZTS Yearly LT Debt VS Equity VS FCFZTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • ZTS has a Current Ratio of 3.03. This indicates that ZTS is financially healthy and has no problem in meeting its short term obligations.
  • ZTS's Current ratio of 3.03 is in line compared to the rest of the industry. ZTS outperforms 52.85% of its industry peers.
  • A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.94, ZTS perfoms like the industry average, outperforming 45.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
ZTS Yearly Current Assets VS Current LiabilitesZTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZTS Growth Analysis

3.1 Past

  • ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
  • The Earnings Per Share has been growing by 10.77% on average over the past years. This is quite good.
  • Looking at the last year, ZTS shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
  • The Revenue has been growing slightly by 7.24% on average over the past years.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • ZTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.41% yearly.
  • Based on estimates for the next years, ZTS will show a small growth in Revenue. The Revenue will grow by 5.25% on average per year.
EPS Next Y6.97%
EPS Next 2Y7.95%
EPS Next 3Y8.12%
EPS Next 5Y8.41%
Revenue Next Year5.01%
Revenue Next 2Y5.09%
Revenue Next 3Y4.98%
Revenue Next 5Y5.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZTS Yearly Revenue VS EstimatesZTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ZTS Yearly EPS VS EstimatesZTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. ZTS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.91, ZTS is valued on the expensive side.
  • 83.94% of the companies in the same industry are more expensive than ZTS, based on the Price/Earnings ratio.
  • ZTS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.29.
  • The Price/Forward Earnings ratio is 17.68, which indicates a rather expensive current valuation of ZTS.
  • ZTS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ZTS is cheaper than 81.35% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ZTS to the average of the S&P500 Index (24.57), we can say ZTS is valued slightly cheaper.
Industry RankSector Rank
PE 18.91
Fwd PE 17.68
ZTS Price Earnings VS Forward Price EarningsZTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 83.42% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 83.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.44
EV/EBITDA 14.65
ZTS Per share dataZTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ZTS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.71
PEG (5Y)1.76
EPS Next 2Y7.95%
EPS Next 3Y8.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ZTS Dividend Analysis

5.1 Amount

  • ZTS has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • ZTS's Dividend Yield is rather good when compared to the industry average which is at 0.68. ZTS pays more dividend than 91.71% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ZTS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of ZTS grows each year by 20.56%, which is quite nice.
  • ZTS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ZTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)20.56%
Div Incr Years11
Div Non Decr Years11
ZTS Yearly Dividends per shareZTS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • ZTS pays out 33.26% of its income as dividend. This is a sustainable payout ratio.
  • ZTS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y7.95%
EPS Next 3Y8.12%
ZTS Yearly Income VS Free CF VS DividendZTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ZTS Dividend Payout.ZTS Dividend Payout, showing the Payout Ratio.ZTS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ZTS Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

NYSE:ZTS (3/6/2026, 8:04:00 PM)

After market: 121.43 0 (0%)

121.43

-0.8 (-0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners100.79%
Inst Owner Change3.97%
Ins Owners0.07%
Ins Owner Change3.93%
Market Cap51.26B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts77.6
Price Target155.47 (28.03%)
Short Float %3.71%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-20
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-4.66%
PT rev (3m)-11.18%
EPS NQ rev (1m)2.55%
EPS NQ rev (3m)2.71%
EPS NY rev (1m)0.23%
EPS NY rev (3m)-1.19%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 18.91
Fwd PE 17.68
P/S 5.65
P/FCF 23.44
P/OCF 18.43
P/B 16.07
P/tB N/A
EV/EBITDA 14.65
EPS(TTM)6.42
EY5.29%
EPS(NY)6.87
Fwd EY5.66%
FCF(TTM)5.18
FCFY4.27%
OCF(TTM)6.59
OCFY5.43%
SpS21.48
BVpS7.56
TBVpS-0.98
PEG (NY)2.71
PEG (5Y)1.76
Graham Number33.04
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.65
F-Score6
WACC9%
ROIC/WACC2.44
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y6.97%
EPS Next 2Y7.95%
EPS Next 3Y8.12%
EPS Next 5Y8.41%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year5.01%
Revenue Next 2Y5.09%
Revenue Next 3Y4.98%
Revenue Next 5Y5.25%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.85%
EBIT Next 3Y9.75%
EBIT Next 5Y8.42%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / ZTS FAQ

What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ZTS.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.


How profitable is ZOETIS INC (ZTS) stock?

ZOETIS INC (ZTS) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for ZTS stock?

The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 6.97% in the next year.


Is the dividend of ZOETIS INC sustainable?

The dividend rating of ZOETIS INC (ZTS) is 7 / 10 and the dividend payout ratio is 33.26%.